EBI3:CANX binds IL12A

Stable Identifier
Reaction [uncertain]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Interleukin-35 is a heterodimer of Interleukin-27 subunit beta (EBI3) and Interleukin-12 subunit alpha (IL12A or IL12-p35) (Devergne et al. 1997). It is required for maximal T regulatory cell activity (Collison et al. 2007).
Site directed mutagenesis of IL12A identified mutations that disrupt formation of Interleukin 12 and Interleukin 27 heterodimeric complexes but not Interleukin 35. IL12A appears to pair with EBI3 entirely differently from IL27. (Jones et al. 2012). In the absence of IL12A, EBI3 is retained in the endoplasmic reticulum, associated with the chaperone Calnexin (CANX) (Devergne et al. 1997).
This is a Black Box event because we know that EBI3 is retained as a complex with CANX and the co expression of EBI3 and IL12A enables their secretion, but we don't have evidence about the mechanism of dissociation of CANX from EBI3 (Devergne et al. 1997).

Literature References
PubMed ID Title Journal Year
22487722 Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family

Jones, LL, Chaturvedi, V, Uyttenhove, C, Van Snick, J, Vignali, DA

Mol. Immunol. 2012
18033300 The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Collison, LW, Workman, CJ, Kuo, TT, Boyd, K, Wang, Y, Vignali, KM, Cross, R, Sehy, D, Blumberg, RS, Vignali, DA

Nature 2007
9342359 Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin

Devergne, O, Birkenbach, M, Kieff, E

Proc. Natl. Acad. Sci. U.S.A. 1997
Participant Of
Cite Us!